In the whole patient group, higher serum calretinin concentration was associated with shorter PFS and shorter OS, but the association was no longer significant after adjusting for clinical factors, indicating that calretinin was not an independent prognostic factor in our patients with MM. This evidence concerns the gene CALB2 and Miyoshi myopathy.